Nobivac NXT FeLV

Authorised

This medicine is authorised for use in the European Union

feline leukemia (self-amplifying RNA particle) vaccine

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Nobivac NXT FeLV
• Active substance:
  feline leukemia virus (FeLV) self-amplifying RNA (saRNA)-particle: 106.6 – 109.3 RP
• International non-proprietary name (INN) or common name:
  feline leukemia (self-amplifying RNA particle) vaccine

Pharmacotherapeutic group

• Immunologicals for felidae
• Other immunologicals

Authorisation details

• EMA product number:
  EMEA/V/C/006683